tk88 bet

Vingroup pledges 840,000 USD for coronavirus research in Vietnam

Private conglomerate Vingroup has pledged nearly 19.5 billion VND (around 840,000 USD) to fund research projects on the novel coronavirus (COVID-19).
Vingroup pledges 840,000 USD for coronavirus research in Vietnam ảnh 1A Vingroup representative (centre) shakes hands with research groups. (Photo courtesy of Vingroup)

Hanoi (VNA)
–Private conglomerate Vingroup has pledged nearly 19.5 billion VND (around840,000 USD) to fund research projects on the novel coronavirus (COVID-19).

The Vingroup InnovationFoundation (VINIF) and Vingroup Big Data Institute (VINBDI) on February 20signed a sponsorship agreement with the Company for Vaccine and BiologicalProduction No.1 (Vabiotech), National Institute of Hygiene and Epidemiology, andInstitute of Preventive Medicine and Public Health to develop a vaccine,warning system and comprehensive research on the virus.

Vabiotech will get 8 billion VND(almost 345,000 USD) for the project on developing COVID-19 vaccine in thelaboratory led by Doctor Do Tuan Dat.

The National Institute ofHygiene and Epidemiology will receive a grant of nearly 7.5 billion VND (323,000USD) for the project on the epidemiological characteristics of coronavirus, ledby Associate Prof. Dr. Phan Trong Lan.

The project to develop anational early warning system for the epidemic led by Prof. Dr. Le Thi Huong ofthe Institute of Preventive Medicine and Public Health will get 4 billion VND (193,000USD).

All funding will be used bythese organisations for research and producing test kits for disease diagnosis;researching treatment regimens; research and manufacture of vaccines; researchon the epidemiological characteristics, viral characteristics and transmissionability of the virus.

Vabiotech is expected toproduce 1,000 doses of novel coronavirus (COVID-19) vaccine.

Speaking at the event, AssociateProf. Dr. Phan Thi Ha Duong, Managing Director of the Vingroup InnovationFoundation (VINIF), expressed her high hope over Vietnam’s scientificcontributions in controlling the epidemic.

“Aiming to promote scientificand technological research in Viet Nam, we look forward to empoweringscientists in research on disease prevention and control which will be veryeffective with the cooperation of the State. Despite being urgent, the selectedprojects have been reviewed strictly by the National Council or the ScienceCouncil of the Foundation,” she said

This agreement makes Vingroupthe first private enterprise to work with the State in controlling the virusand protecting public health./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

♏ Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

♏ Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

ꦉ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|